Legend Capital, established in 2001, is a Beijing-based venture capital firm and subsidiary of Legend Holdings Ltd. It manages multiple funds totaling up to US$700 million, focusing on early-stage IT companies and mid-market growth stage companies in China. Its investment sectors include network applications and services, outsourcing, professional services, IC design, key components, consumer goods, clean technology, healthcare, and modern services. Legend Capital actively supports its portfolio companies, providing business resources and tailored services to facilitate growth and enhance returns. Notable portfolio companies include Joyo.com (acquired by Amazon.com) and Spreadtrum Communications (Nasdaq: SPRD).
10/F, Tower A, Raycom Info.Tech Center, No.2 Ke Xue Yuan Nanlu, Zhong Guan Cun, Haidian District, Beijing 100190, China
Daqing Cai
Managing Director
Hao Chen
Managing Director and Head of Investment
Raymond CHEN
Co-Chief Investment Officer
Rui Chen
Managing Director
Frank Hong
Managing Director
Henry Ji
Executive Director
Yi Kang
Director
Richard Li
President
Jiaqing Li
Managing Director
Joon Sung Park
Executive Director
FAN Qihui
Executive Director
Jenking Shao
Managing Director and Partner
Zhenxing Shao
Partner / Managing Director
Jeff Wang
Managing Director
Junfeng Wang
Managing Director
Nengguang Wang
Managing Director and CFO
Piau-Voon Wang
COO
Tony WANG
VP
Ge Xinyu
Managing Director
Quan Zhou
Managing Director, Partner
Hank Zhou
Executive Director
Hongbin Zhou
Managing Director
Linan Zhu
Chairman
William Wen
Executive Director
Past deals in Growth Stage
AiCheng Technology
Series B in 2025
Suzhou Aicheng Technology is an organization that seamlessly integrates research and development (R&D) with production processes.
Volant Aerotech
Series B in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
Angitia Biopharmaceuticals
Series C in 2024
Angitia Biopharmaceuticals is a global biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company focuses on researching and creating breakthrough therapies aimed at treating conditions affecting bones, muscles, and joints. By prioritizing the development of novel drugs, Angitia Biopharmaceuticals aims to improve patient outcomes and facilitate recovery from severe musculoskeletal ailments.
Hohem
Series B in 2024
Hohem is a camera gimbal developer specialized in the research, development, and design of drone flight control and image stabilization systems. Its key products are automatic face tracking shooting stabilizer, Bat vision positioning multi-rotor flight control system, Bfly multi-rotor flight control system, and Bee cross-country multi-rotor flight control system.
Nuwacell
Series B in 2024
Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.
Macrolux Medical
Series B in 2024
MacroLux is a medical technology company that specializes in endoscopic interventional solutions for diagnosis and treatment. The company focuses on developing devices that enhance the detection and treatment of conditions in urology, respiratory, and digestive health. By offering advanced endoscopic therapies, MacroLux aims to improve patient outcomes through earlier diagnosis and more effective treatment options, catering to a wide range of medical customers.
RUICYCLE
Series C in 2024
RUICYCLE is a high-tech company dedicated to the comprehensive recycling and utilization of lithium batteries. The company specializes in developing solutions for lithium battery recovery, encompassing cascade utilization, material regeneration, and new material recycling. RUICYCLE's innovative technologies offer industry users a closed-loop ecosystem that emphasizes automatic safe crushing and environmentally friendly treatment processes. By focusing on zero pollution and efficient recycling, RUICYCLE aims to address the challenges associated with lithium battery waste and contribute to sustainable practices in the industry.
Dearer Medical
Series C in 2024
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.
Leapstack
Series C in 2023
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.
Angitia Biopharmaceuticals
Series B in 2023
Angitia Biopharmaceuticals is a global biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company focuses on researching and creating breakthrough therapies aimed at treating conditions affecting bones, muscles, and joints. By prioritizing the development of novel drugs, Angitia Biopharmaceuticals aims to improve patient outcomes and facilitate recovery from severe musculoskeletal ailments.
Saige Research
Series B in 2023
Saige Research is a company that focuses on providing artificial intelligence solutions specifically for the manufacturing sector, particularly in the area of industrial inspection and quality control. The firm has developed a deep learning vision inspection platform that addresses the challenges faced by inspectors, enhancing work efficiency. This technology offers capabilities such as power detection, speed detection, and versatility, allowing for greater convenience in development. By automating the inspection process, Saige Research aims to deliver optimal AI solutions that improve quality assurance in manufacturing environments.
Zhipu AI
Series B in 2023
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.
HC Scientific
Series B in 2023
HC Scientific (Chengdu) L.L.C., founded in early 2016, focuses on developing intelligent solutions within the life sciences sector. The company aims to be a trusted partner for global clients by offering innovative products, including genetic testing instruments, reagents, and software. These products are primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is recognized as a national high-tech enterprise, emphasizing autonomous research and the development of intellectual property. The company participates in significant national and provincial scientific initiatives and is supported by a team of experts, including returning PhDs. Its product offerings streamline complex tasks for life science practitioners, delivering high-throughput, automated, and cost-effective genetic testing solutions while creating value for collaborative partners.
Jinqirui Biology
Series C in 2023
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.
Tailan New Energy
Series B in 2023
Tailan New Energy is a company dedicated to the research and development of innovative energy technologies, specifically new solid-state lithium batteries and essential lithium battery materials. Co-founded by experts in lithium battery research and a seasoned industrialization team, it aims to advance the technology and commercialization of these batteries. The company also focuses on electronic special materials and resource recycling, offering a range of services that includes battery sales, battery leasing, and the sale of graphite and carbon products. Through its efforts, Tailan New Energy seeks to contribute to the evolving landscape of energy storage solutions.
Open Source China
Series B in 2023
Open Source China is a prominent community focused on open source technology, providing a platform for IT developers to discover, utilize, and exchange open source software. The community offers various resources, including open source software libraries, code sharing, discussion forums, and collaborative translation services. It serves as a hub for technical support, allowing users to seek answers to software-related questions and access relevant information. By fostering collaboration and knowledge sharing, Open Source China promotes the development and application of open source technologies among domestic developers, enhancing their ability to innovate and improve these technologies.
Bio-Engine
Series C in 2023
Bio-Engine specializes in the research and development of veterinary biological products, focusing on the creation and manufacturing of antibodies, recombinant proteins, and vaccines for both human and livestock viruses. The company utilizes high-density serum-free suspension culture technology for animal cells, which enhances the efficiency of its products. Key offerings include serum-free media for various cell types, such as HEK293 and PK15, applicable in fields like cell therapy and vaccine production. In addition to product development, Bio-Engine provides clinical trial services to pharmaceutical manufacturers and scientific research organizations. Founded in 2014 and headquartered in Shanghai, China, the company is committed to advancing biotechnological solutions in the veterinary sector.
TriApex
Series C in 2023
TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises and research institutions.
DentaFilm
Series B in 2023
DentaFilm is a provider of oral intelligent equipment and a full-chain platform (FICP), concentrating on the advancement of both digital cloud platforms and oral intelligent equipment. It focuses on oral equipment for data collection, data storage, data transmission, data management, and data applications, covering clinic 2D, and 3D image data, CAD/ CAM design, clinic ERP system, PMS, equipment IoT intelligent management.
Rongke Power
Series B in 2023
Rongke Power specializes in the development and manufacture of vanadium redox flow batteries, focusing on safe and reliable energy storage solutions. The company offers a variety of products, including container energy storage systems and comprehensive energy storage solutions, as well as operation and maintenance services for power stations. By providing these innovative energy storage products, Rongke Power aims to support enterprises in creating cleaner and more energy-efficient energy grids. Additionally, the company has established itself as an independent provider of intellectual property rights related to its battery technologies.
Tripod Preclinical Research
Funding Round in 2023
Tripod Preclinical Research is a Contract Research Organization that specializes in providing preclinical research services to the biopharmaceutical and medical device industries. The company offers a comprehensive range of services, including drug safety evaluation for new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Tripod's expertise encompasses non-human primate disease models, pharmacological efficacy studies, early drug evaluation, and Good Laboratory Practices (GLP) toxicology. Additionally, the organization supports translational medicine and clinical trials, along with biological analysis and the management of biological sample banks. By delivering these services, Tripod aids drug developers and researchers in advancing their projects through the critical early stages of research and development.
ZStack
Series C in 2023
ZStack is a provider of cloud computing services focused on making cloud technology more accessible for enterprises across various industries, including government, finance, education, and manufacturing. The company offers a range of solutions, including private and hybrid cloud systems, mini hyper-converged machines, and a cloud management platform. Additionally, ZStack provides enterprise-class distributed storage and other cloud-related products, enabling businesses to manage their data center resources—covering computing, networking, and storage—under a unified framework. With a client base of over 2,500 enterprise users, ZStack has also formed partnerships with more than 250 cloud vendors to enhance its ecosystem and channel offerings.
SJ Semi
Series C in 2023
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.
ProBio
Series C in 2023
ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.
ClinBrain
Series C in 2022
ClinBrain develops a hospital information integration platform aimed at improving healthcare services through the digitization and standardization of patient data alongside medical and clinical data. This platform is designed to enhance the efficiency of medical research by providing hospitals with comprehensive healthcare big data services. By facilitating the integration of diverse data sources, ClinBrain supports healthcare professionals in making informed decisions and advancing medical research initiatives.
VectorBuilder
Series C in 2022
VectorBuilder is an online platform specializing in vector cloning and gene delivery solutions, catering to a range of needs from basic scientific research to clinical applications. The platform enables researchers to design and order custom gene delivery vectors efficiently, streamlining the process of vector construction and production. VectorBuilder offers a comprehensive suite of services, including vector customization, virus packaging, and advanced capabilities in adeno-associated virus capsid engineering. Additionally, the company provides Contract Research Organization (CRO) services and operates state-of-the-art facilities compliant with Good Manufacturing Practices (GMP), ensuring high-quality gene delivery tools for life sciences research and drug development.
Shuhai Supply Chain
Series B in 2022
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.
Leadrive
Series C in 2022
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance power semiconductor modules. The company designs and manufactures advanced motor controllers and proprietary power modules that have been adopted by over ten leading automotive manufacturers and Tier-1 suppliers for mass production. LEADRIVE is also engaged in enhancing the localization of power semiconductor modules, with ongoing certification processes for silicon carbide modules and electronic controls. Additionally, the company invests in innovative energy solutions, including wind, solar, and energy storage systems. In collaboration with Rohm Semiconductor from Japan, LEADRIVE has established a joint laboratory to develop various silicon carbide modules, focusing on improving efficiency through comprehensive simulation, testing, and development processes that span from device-level to vehicle-level applications.
APTBIO
Series B in 2022
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.
RUICYCLE
Series B in 2022
RUICYCLE is a high-tech company dedicated to the comprehensive recycling and utilization of lithium batteries. The company specializes in developing solutions for lithium battery recovery, encompassing cascade utilization, material regeneration, and new material recycling. RUICYCLE's innovative technologies offer industry users a closed-loop ecosystem that emphasizes automatic safe crushing and environmentally friendly treatment processes. By focusing on zero pollution and efficient recycling, RUICYCLE aims to address the challenges associated with lithium battery waste and contribute to sustainable practices in the industry.
Tianfu
Series C in 2022
Nanjing Tianfu Software Co., Ltd. is a developer of custom software solutions and intelligent industrial software based in Nanjing, China. Founded in 2011, the company serves various industries, including turbomachinery, hydraulic construction, automotive, aerospace, and shipbuilding. Its offerings encompass a range of technical services, such as CAE pre- and post-processing development, special solver development, industrial design platform construction, and artificial intelligence platform development. Tianfu focuses on meeting the specific needs of its clients by providing tailored software solutions that enhance efficiency and innovation across different sectors.
Joymed Technology
Series B in 2022
Joymed Technology specializes in the research and development, registration, and manufacturing of medical devices, providing comprehensive solutions tailored for medical equipment businesses. The company focuses on delivering innovative and reliable technology while ensuring high-quality standards in its products. By offering services such as device design, risk management, marketing, and product verification and validation, Joymed Technology enables its clients to develop and launch safe and affordable medical products efficiently. The company aims to become a trusted partner for both domestic and international medical device firms, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through flexible collaboration and optimized design processes, Joymed Technology seeks to accelerate mutual growth with its customers.
TBSTest
Venture Round in 2022
TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.
Lipinyun
Series B in 2022
Lipinyun is a tencent strategic investment company. They offer a full-process intelligent sales model, from customer acquisition and screening to customer management and digital asset accumulation, for enterprises diverse sales ecology. Their integration solution helps enterprises realize the upgrade and iteration of digital business.
ZHIYI TECH
Series B in 2022
Zhiyi Tech develops a supply chain platform for intelligent clothing design. They offer services for digitalized trend forecasting, design selection, and supply chain organization. They provide clothing companies with core functions such as fashion trend prediction, design empowerment, and style recommendation, and expand to the downstream of the industrial chain via the SaaS portal, providing one-stop design and flexible production supply chain platform services.
Qingwei Intelligent Technology
Series B in 2022
Qingwei Intelligent Technologies creates artificial intelligence chips that may be reconfigured to improve energy efficiency. The company's chips are designed with low power consumption, intelligent speech and visual features in mind, providing customers with a better consumer electronics experience and application.
MediLink Therapeutics
Series B in 2022
MediLink Therapeutics is a biotechnology company based in Suzhou, China, specializing in the development of next-generation antibody-drug conjugates (ADCs). The company aims to address significant unmet medical needs in China by creating innovative therapeutics that target cancer while minimizing damage to healthy cells. MediLink Therapeutics is committed to enhancing patient outcomes through its research and development efforts, which include conducting multicenter clinical trials and engaging in cross-border collaborations to generate global value. By focusing on ADCs, the company strives to improve the efficacy of cancer treatments while ensuring patient safety during therapy.
Inceptio Technology
Series B in 2022
Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.
Zhipu AI
Series B in 2022
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.
Hoteam Software
Series C in 2022
Hoteam Software is a provider of intelligent manufacturing solutions aimed at transforming enterprise operations. The company emphasizes independent innovation and the development of controllable industrial software to support the advancement of China's industrial sector. Hoteam Software specializes in 3D software and offers a comprehensive range of services, including computer-aided design (CAD), computer-aided manufacturing (CAM), computer-aided process planning (CAPP), product data management (PDM), product lifecycle management (PLM), manufacturing execution systems (MES), warehouse management systems (WMS), and supplier relationship management (SRM). By leveraging its technology platforms, Hoteam Software enables industrial enterprises to enhance work efficiency and reduce operational costs through three-dimensional design, intelligent management, and visualization capabilities.
Singlomics
Series B in 2022
Singlomics is a biotechnology company that specializes in single-cell sequencing technology to facilitate antibody drug development aimed at treating infectious diseases and cancers. The company has made significant advancements in antibody discovery, having developed neutralizing antibodies such as DXP593 and DXP604, which offer potential solutions in the fight against COVID-19. By leveraging its innovative technology, Singlomics focuses on creating targeted therapies that address critical health challenges.
Zshield
Series C in 2022
Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.
Beijing Tianxing
Series B in 2022
Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.
Leapstack
Series C in 2021
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.
Xbiome
Series B in 2021
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.
ColorTech Bio
Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.
River Security
Series C in 2021
River Security specializes in advanced cybersecurity solutions, focusing on fraud risk protection and dynamic application security. Established in 2012 with headquarters in Shanghai, Beijing, and Shenzhen, the company has developed innovative technologies that enhance the security of corporate website applications and safeguard business data. Its dynamic security bot-gate product utilizes a unique approach to predict server behavior by transforming the underlying code of web pages, allowing for more efficient and timely defenses against various modern cyber attacks. This technology represents a significant departure from traditional security methods, enabling businesses to reduce deployment and operational costs while improving overall security effectiveness.
Jifan Biotechnology
Series B in 2021
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.
LePure Biotech
Series B in 2021
Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples in biosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&D market operation team at home and abroad.
Eswin
Series C in 2021
Eswin specializes in integrated circuit (IC) application solutions across various sectors, including mobile devices, smart homes, smart transportation, and industrial IoT. The company manufactures 12-inch monocrystalline silicon polished and epitaxial wafers, which are essential for semiconductor production. Eswin is dedicated to optimizing advanced equipment and processes to produce high-quality, dislocation-free, ultra-flat silicon wafers, primarily utilized for logic chips, flash memory chips, dynamic random access memory (DRAM), image sensors, and display driver ICs. Additionally, Eswin offers rear-end IC packaging and testing services. The company operates research and development centers in China, the U.K., and South Korea, along with production facilities located in Xi'an, Chengdu, Hefei, and Suzhou.
Wuxi Biortus Biosciences
Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization based in Jiangyin, China, specializing in research and development services that support drug discovery. Founded in 2009, the company offers a range of services, including recombinant protein production, in vitro assays and screening, medicinal chemistry, structural biology, and target validation. Wuxi Biortus Biosciences is recognized for its commitment to quality and innovation, having established five advanced research platforms that enhance its capabilities in drug development. The company’s R&D team has developed various innovative techniques, some of which have been patented, further solidifying its role in the biotechnology sector. It operates as a subsidiary of Jiangsu Shuangliang Group Company Ltd.
ForQaly
Series B in 2021
ForQaly specializes in the development of minimally invasive ventricular assist devices designed to treat heart failure patients. The company focuses on creating therapeutic devices that enhance circulation while ensuring affordability for patients. Their products are characterized by features such as reduced trauma, high auxiliary flow, and user-friendly design, providing healthcare professionals with effective solutions for improving patient health. By combining innovation with accessibility, ForQaly aims to address the clinical needs of patients suffering from heart conditions.
H.Extract
Series C in 2021
H.Extract is a company focused on the research, development, promotion, and sales of pharmaceutical ERP solutions. As a leading brand in China's pharmaceutical distribution sector, H.Extract has implemented its Cloud ERP System in over 40,000 pharmacies nationwide. The company formed a strategic partnership with Tencent Cloud and WeChat Pay in 2016 to enhance the efficiency of the medicine distribution industry, particularly in pharmaceutical wholesale and chain drugstores. With 14 years of experience, H.Extract leverages its technical expertise and management skills to cater to a diverse client base, including major players in the pharmaceutical sector such as Harbin Pharmaceutical Group and Hainan Zhangzhongjing Dispensary. The company's commitment to innovation and high-quality service aims to streamline operations within the pharmaceutical supply chain.
HC Scientific
Series B in 2021
HC Scientific (Chengdu) L.L.C., founded in early 2016, focuses on developing intelligent solutions within the life sciences sector. The company aims to be a trusted partner for global clients by offering innovative products, including genetic testing instruments, reagents, and software. These products are primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is recognized as a national high-tech enterprise, emphasizing autonomous research and the development of intellectual property. The company participates in significant national and provincial scientific initiatives and is supported by a team of experts, including returning PhDs. Its product offerings streamline complex tasks for life science practitioners, delivering high-throughput, automated, and cost-effective genetic testing solutions while creating value for collaborative partners.
LYNK Pharmaceuticals
Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.
Berry Oncology
Series B in 2021
Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.
QANDA(Mathpresso)
Series C in 2021
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.
YEASEN Biotechnology
Series B in 2021
Yeasen is a biotechnology company that provides molecular enzymes, proteins, antibodies, nucleic acids, and cells. They produce fields of life science research, diagnosis and detection, and biomedicine.
Horizon Robotics
Series C in 2021
Horizon Robotics is a prominent provider of advanced driver assistance systems (ADAS) and autonomous driving solutions specifically designed for passenger vehicles. The company develops proprietary software and hardware that integrate advanced algorithms and specialized processing capabilities. These technologies form the foundation for enhanced driving automation, aiming to improve both safety and the overall experience for drivers and passengers. By focusing on innovative solutions, Horizon Robotics plays a key role in the evolution of assisted and autonomous driving.
Bloks Technology Group
Series B in 2021
Bloks Group uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bloks Group strives to create a whole ecological industry chain with "building blocks +" as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.
Dearer Medical
Series B in 2021
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.
Fiture Technology
Series B in 2021
Fiture is a fitness technology company focused on transforming home fitness through innovative hardware and artificial intelligence. The company offers customized online workout courses alongside the manufacturing of intelligent home workout equipment. By leveraging AI technologies, Fiture aims to enhance user experience and support clients in achieving healthier lifestyles through effective at-home fitness solutions.
Stonewise
Series B in 2021
StoneWise is a technology company established in 2018 that focuses on enhancing the drug discovery process through artificial intelligence. The company aims to transform traditional drug research and development by implementing a dual-engine model that combines advanced AI technology with expert systems. Its platform utilizes cutting-edge technologies, including microfluidics, computational chemistry, computational biology, pharmacology, and clinical medicine, to offer integrated solutions for pharmaceutical companies. These solutions encompass a variety of tools, such as medical knowledge graphs, molecular generation and design, and predictions of reaction products and synthetic pathways. By leveraging this innovative platform, StoneWise seeks to improve the efficiency and success rates of early-stage drug discoveries. The company collaborates with both domestic and international experts in various scientific fields, and maintains a state-of-the-art facility to stay abreast of the latest advancements in drug discovery.
Sciwind Biosciences
Series B in 2021
Hangzhou Sciwind Biosciences Co., Ltd. is a biotechnology company specializing in the development and sale of protein and peptide drugs aimed at treating various diseases. Founded in 2017 and located in Hangzhou, China, the company focuses on therapeutic areas such as diabetes, obesity, metabolic liver diseases, diabetic retinopathy, and neuro-degenerative conditions. Sciwind's innovative drug candidates are particularly targeted at metabolic disorders, including non-alcoholic steatohepatitis, providing enhanced treatment options for healthcare professionals and their patients.
Liangyihui
Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. operates an authoritative online education and information platform focused on oncology. Based in Shanghai, China, the company collaborates with numerous reputable hospitals and institutions, both domestically and internationally, to address the information asymmetry in the cancer field. Liangyihui provides a comprehensive range of educational materials related to tumor treatment, including medical cases, conference information, online courses, and research reports. This platform serves as a valuable resource for oncologists and aims to enhance public understanding of cancer, promoting scientific knowledge and supporting efforts to prevent and combat the disease.
Exegenesis Bio
Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
Jinqirui Biology
Series B in 2020
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.
Wangdiantong
Series C in 2020
Wangdiantong ERP is a provider of enterprise-level e-commerce solutions that facilitate the integration of online and offline retail operations. The company's services encompass a range of functionalities, including inventory management, order processing, purchasing, after-sales service, and customer relationship management. By supporting major platforms such as Taobao, Tmall, Jingdong, Amazon, and Alibaba, Wangdiantong enables businesses to effectively manage multi-warehouse systems and streamline operations for both online stores and physical retail locations. Additionally, the company offers intelligent warehouse solutions and cloud-based services designed to assist enterprises in transitioning to digital management and scaling their operations efficiently.
Xbiome
Series B in 2020
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.
Kunya Medical
Series C in 2020
Kunya Medical is a provider of medical equipment management services focused on enhancing the maintenance and operational efficiency of hospital equipment. The company offers comprehensive services, including the maintenance and hosting of hospital imaging and radiation equipment, as well as installation, debugging, and repair of large and medium-sized medical devices. Kunya Medical also supplies spare parts and management software, facilitating improved oversight and longevity of clinical medical equipment for hospitals. By outsourcing these critical functions, Kunya Medical aims to help healthcare facilities optimize their equipment management and extend the lifecycle of their medical assets.
GalaxySpace
Series C in 2020
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
Aqrose Technology
Series B in 2020
Aqrose Technology Co., Ltd., founded in 2017 from the AI Lab of Tsinghua University, specializes in the application of advanced artificial intelligence and machine vision technologies in industrial settings. The company provides a range of products, including its standardized intelligent industrial vision platform AIDI and the AIPICK intelligent inspecting and sorting robot, which utilize 3D vision technology for automation. Aqrose's solutions support various sectors such as consumer electronics, automotive, new energy, pharmaceuticals, semiconductors, and logistics, enhancing manufacturing processes and product quality. With deployments in over 100 factories, including leading enterprises in advanced manufacturing and smart logistics, Aqrose is committed to empowering its clients through innovative technology.
Genskey
Series C in 2020
GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. Utilizing high-throughput sequencing technology and intelligent algorithm analysis, GensKey addresses traditional challenges such as low detection rates, lengthy processes, and diagnostic accuracy. This innovative approach allows for timely and precise diagnoses for patients suffering from severe infections, ultimately improving patient outcomes by facilitating quicker access to appropriate medical interventions.
Hemu (China) Biological Engineering
Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.
HEMO BIOENGINEERING
Series B in 2020
HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.
Leadrive
Series B in 2020
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance power semiconductor modules. The company designs and manufactures advanced motor controllers and proprietary power modules that have been adopted by over ten leading automotive manufacturers and Tier-1 suppliers for mass production. LEADRIVE is also engaged in enhancing the localization of power semiconductor modules, with ongoing certification processes for silicon carbide modules and electronic controls. Additionally, the company invests in innovative energy solutions, including wind, solar, and energy storage systems. In collaboration with Rohm Semiconductor from Japan, LEADRIVE has established a joint laboratory to develop various silicon carbide modules, focusing on improving efficiency through comprehensive simulation, testing, and development processes that span from device-level to vehicle-level applications.
Haihe Biopharma
Series B in 2020
Haihe Biopharma is dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and highly selective oral c-Met inhibitors. By focusing on these advancements, Haihe Biopharma seeks to enhance health outcomes for patients and improve the quality of research in the pharmaceutical field.
Tongcheng Shenghuo
Series C in 2020
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.
ESWIN Computing
Series B in 2020
ESWIN Computing specializes in the research and development of RISC-V computing architecture, focusing on the design and testing of integrated circuits for Internet of Things (IoT) applications. The company develops chips used in display devices and wearable technology, providing comprehensive solutions in areas such as artificial intelligence, human-computer interaction, and the Internet of Vehicles. By combining innovative design with advanced materials, ESWIN Computing aims to enhance user experiences across various digital platforms.
Uditech
Series B in 2020
Uditech is a high-tech enterprise with technology as its core and innovation-oriented.
iBeiDiao
Series B in 2020
iBeiDiao is an intelligent employee background investigation service-providing company. They provide objective background-checking services and employee onboarding management solutions for employees using artificial intelligence, providing employee credit reference information for enterprises.
Wangdiantong
Series B in 2020
Wangdiantong ERP is a provider of enterprise-level e-commerce solutions that facilitate the integration of online and offline retail operations. The company's services encompass a range of functionalities, including inventory management, order processing, purchasing, after-sales service, and customer relationship management. By supporting major platforms such as Taobao, Tmall, Jingdong, Amazon, and Alibaba, Wangdiantong enables businesses to effectively manage multi-warehouse systems and streamline operations for both online stores and physical retail locations. Additionally, the company offers intelligent warehouse solutions and cloud-based services designed to assist enterprises in transitioning to digital management and scaling their operations efficiently.
Healing Paper
Series B in 2020
Healing Paper operates a platform focused on enhancing access to cosmetic surgery services while promoting transparency and affordability. The company utilizes information and communication technology to provide patients with estimates for necessary procedures, honest reviews, and special pricing options. In addition to connecting patients with cosmetic treatment options, Healing Paper fosters a real-time community for sharing experiences and offers management tools for post-surgery care. By balancing information between medical professionals and patients, Healing Paper aims to improve the quality of cosmetic beauty services and make them more accessible.
ANYCOLOR
Post in 2020
ANYCOLOR is an entertainment startup that specializes in supporting and managing the Nijisanji Project, which features virtual talents known as VTubers. The company focuses on creator support and licensing, enabling the operation of virtual talents to engage audiences worldwide. By leveraging advanced technology, ANYCOLOR aims to provide innovative experiences that enrich daily life and reflect contemporary societal themes. Through its commitment to the VTuber phenomenon and other emerging projects, the company seeks to shape the future of digital entertainment.
Harbour BioMed
Series B in 2020
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.
Genskey
Series B in 2020
GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. Utilizing high-throughput sequencing technology and intelligent algorithm analysis, GensKey addresses traditional challenges such as low detection rates, lengthy processes, and diagnostic accuracy. This innovative approach allows for timely and precise diagnoses for patients suffering from severe infections, ultimately improving patient outcomes by facilitating quicker access to appropriate medical interventions.
Lunit
Series C in 2019
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
Nanovision
Series B in 2019
Nanovision Technology, based in the Zhongguancun Yongfeng high-tech industrial base with an additional subsidiary in Chengdu, specializes in high-speed and high-precision radiology imaging. The company focuses on the development of static CT, X-ray CMOS detectors, and X-ray imaging software. Notably, Nanovision created China's first self-developed CMOS flat panel detector, known as the Merak series. Its products are applicable in various sectors, including medical, industrial, and security, offering advanced technological support both domestically and internationally. With a significant research and development foundation, Nanovision is positioned as a key player in the radiation imaging industry.
Dongfang Weiyin
Series C in 2019
Dongfang Weiyin is a small and micro enterprise financial service platform.
Suzhou Ribo Life Science
Series C in 2019
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
RT-Thread
Series B in 2019
RT-Thread is a Shanghai-based company established in 2006 that specializes in developing an open-source real-time operating system (RTOS) for embedded devices. The RTOS is designed for a wide range of applications, particularly in the Internet of Things (IoT) sector, offering features such as cross-chip compatibility, cloud integration, ultra-low power consumption, and security. The system includes a device virtual file system, a device manager framework, low-power management, and firmware update capabilities. RT-Thread supports both resource-constrained microcontroller systems with its Nano version, which requires minimal memory, and more resource-rich IoT devices, allowing for modular customization through user-friendly tools. The company serves various industries, including new energy, home appliances, and transportation, providing a stable and scalable platform that facilitates easy access to major IoT cloud services.
Xbiome
Series B in 2019
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.
Gambol Pet Group
Series B in 2019
Gambol Pet Group Co., Ltd is a pet food manufacturer based in Liaocheng City, China, founded in 2006. The company specializes in a diverse range of products, including dry and wet pet food, real meat jerky treats, rawhide chews, and dental bones, catering to both dogs and cats. Its product lineup features various categories such as pet treats made from chicken, duck, pork, lamb, and fish, as well as wet food incorporating meat, fruits, and vegetables. Gambol Pet Group is committed to research and development, ensuring that its offerings include nutritional supplements and natural ingredients. The company distributes its products across Europe, Asia, and North America, serving a wide customer base. Under the leadership of Chairman and CEO Qin Hua, Gambol Pet Group continues to expand its presence in the pet food industry.
dMed
Series B in 2019
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.
QANDA(Mathpresso)
Series B in 2019
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.
GalaxySpace
Series B in 2019
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
GKHT Medical Technology
Series C in 2019
Guoke Hengtai (Beijing) Medical Technology Co., Ltd., established in February 2013, is a company based in the Yizhuang Economic and Technological Development Zone of Beijing. It operates under the umbrella of Oriental Science and Technology Holding Group Co., Ltd., a subsidiary of the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. The company specializes in the distribution and direct sales of medical devices, offering a range of professional services, including warehousing logistics, distribution channel management, and hospital SPD operation management. Since its inception, Guoke Hengtai has experienced significant growth, achieving a compound annual growth rate exceeding 50% over four years and embarking on an initial public offering journey in 2017.
AgotoZ
Series B in 2019
AgotoZ Technology, established in 2017 as Guanmai Technology (Beijing) Co., Ltd., specializes in providing high-speed network transmission services tailored for enterprises. The company focuses on WAN high-speed transmission core technology, big data computing, and security defense solutions. By leveraging its capabilities in resource calculation and security, AgotoZ aims to enhance the efficiency and interoperability of enterprise networks. Through independent research and development, it offers advanced technologies and products designed to meet the evolving needs of businesses seeking reliable and efficient network transmission solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.